CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY (Parenthetical) - P3 Health Partners Inc. |
1 Months Ended |
|---|---|
|
Dec. 31, 2021
USD ($)
| |
| Additional Paid-in Capital | |
| Business Combinations, including the PIPE investment (net of issuance costs) | $ 195,300,000 |
| Trust proceeds (net of redemptions) | 37,400,000 |
| P3 Llc | Additional Paid-in Capital | |
| Equity consideration transferred | $ 80,300,000 |
| X | ||||||||||
- Definition Value of shares for business combination and PIPE investment included in opening balance. No definition available.
|
| X | ||||||||||
- Definition Amount of trust proceeds net of redemption. No definition available.
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|